
Join to view full profile
9500 Euclid AvenueCleveland, OH 44195
Dr. Berube is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2026 - 2029
Cleveland Clinic FoundationChief Residency, Internal Medicine, 2025 - 2026
Cleveland Clinic FoundationResidency, Internal Medicine, 2022 - 2025
University of Tennessee Health Science Center College of MedicineClass of 2022
Boston UniversityBA, Neuroscience, 2013 - 2017
Certifications & Licensure
CA State Medical License 2026 - 2028
OH State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.Moaath K Mustafa Ali, Emily C Zabor, Kamilla Abdurakhmanov, Hadil Zureigat, Ahmed N Mohamed
Cancer. 2026-07-15 - 4 citationsA Structure-Function-Inhibition Analysis of the Pseudomonas aeruginosa Type III Secretion Needle Protein PscF.Donald T. Moir, Nicholas O. Bowlin, Bryan J. Berube, Jaden Yabut, Debra M. Mills
Journal of Bacteriology. 2020-08-25
Grant Support
- Next Generation pan-serotype,antitoxin for botulinum neurotoxin exposuresTUFTS UNIVERSITY BOSTON2026–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: